Ovarian cancer and menopausal hormone therapy in the NIH-AARP diet and health study

BACKGROUND: Women using unopposed estrogens during menopause are at increased risk of ovarian cancer. It is uncertain whether oestrogen plus progestin therapy exerts similar effects. METHODS: We evaluated menopausal hormone use and incident ovarian cancer (n=426) in 92 601 post-menopausal women enro...

Descripción completa

Detalles Bibliográficos
Autores principales: Trabert, B, Wentzensen, N, Yang, H P, Sherman, M E, Hollenbeck, A, Danforth, K N, Park, Y, Brinton, L A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2012
Materias:
Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3461172/
https://www.ncbi.nlm.nih.gov/pubmed/22929888
http://dx.doi.org/10.1038/bjc.2012.397

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3461172/
https://www.ncbi.nlm.nih.gov/pubmed/22929888
http://dx.doi.org/10.1038/bjc.2012.397

Ejemplares similares